Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...
Rabies01:28

Rabies

Rabies is a lethal zoonotic disease caused by a single-stranded, negative-sense RNA virus of the Lyssavirus genus, within the family Rhabdoviridae. Its primary mode of transmission to humans is through bites or saliva-contaminated scratches from infected mammals such as dogs, bats, raccoons, or foxes. Transmission can also occur if infectious saliva contacts abraded skin or intact mucous membranes, including the conjunctiva.Viral Entry and Early ReplicationOnce introduced at the bite or scratch...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Prediction of Radiation-induced Lymphopenia following Exposure of the Thoracic Region and Associated Risk of Infections and Mortality.

Clinical oncology (Royal College of Radiologists (Great Britain))·2023
Same author

Changes in alanine aminotransferase levels after switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) in HIV-positive people without viral hepatitis in the Swiss HIV Cohort Study.

HIV medicine·2021
Same author

Hyperglycaemia and pharmacokinetics of rifampicin/isoniazid among TB-HIV co-infected patients in Kampala, Uganda.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2020
Same author

The EuroSIDA study: 25 years of scientific achievements.

HIV medicine·2019
Same author

Why do sub-Saharan Africans present late for HIV care in Switzerland?

HIV medicine·2019
Same author

Comparison of Löwenstein-Jensen and BACTEC MGIT 960 culture for Mycobacterium tuberculosis in people living with HIV.

HIV medicine·2018

相关实验视频

Updated: Jul 7, 2026

Isolation of Fidelity Variants of RNA Viruses and Characterization of Virus Mutation Frequency
18:10

Isolation of Fidelity Variants of RNA Viruses and Characterization of Virus Mutation Frequency

Published on: June 16, 2011

与强抗逆转录病毒治疗相关的不良事件的发生率:瑞士艾滋病毒队列研究.

J Fellay1, K Boubaker, B Ledergerber

  • 1University Hospital of Lausanne, Lausanne, Switzerland.

Lancet (London, England)
|October 31, 2001
PubMed
概括

对HIV-1的抗逆转录病毒治疗导致频繁的不良事件,在双重或三类疗法中观察到更严重的毒性效应. 这项研究确定了特定的药物毒性,以更好地管理患者.

更多相关视频

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
12:03

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Published on: September 5, 2016

Reverse Genetics to Engineer Positive-Sense RNA Virus Variants
15:49

Reverse Genetics to Engineer Positive-Sense RNA Virus Variants

Published on: June 9, 2022

相关实验视频

Last Updated: Jul 7, 2026

Isolation of Fidelity Variants of RNA Viruses and Characterization of Virus Mutation Frequency
18:10

Isolation of Fidelity Variants of RNA Viruses and Characterization of Virus Mutation Frequency

Published on: June 16, 2011

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
12:03

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Published on: September 5, 2016

Reverse Genetics to Engineer Positive-Sense RNA Virus Variants
15:49

Reverse Genetics to Engineer Positive-Sense RNA Virus Variants

Published on: June 9, 2022

科学领域:

  • 药理学和毒理学 药理学和毒理学
  • 传染性疾病 传染性疾病
  • 艾滋病毒/艾滋病 治疗

背景情况:

  • 关于抗逆转录病毒治疗不良事件的现有数据可能不反映当前的综合治疗组合.
  • 需要对与强效抗逆转录病毒疗法相关的不良事件进行最新评估.

研究的目的:

  • 评估在接受抗逆转录病毒治疗的患者中不良事件的发生率.
  • 为了确定与特定药物疗法和化合物相关的有毒效应.

主要方法:

  • 用于评估1160名接受抗逆转录病毒治疗的患者的标准临床和实验室方法.
  • 多变量分析用于测量蛋白酶抑制剂 (PI),非核酸和核酸模拟逆转录酶抑制剂的毒性作用.
  • 与特定抗逆转录病毒化合物相关的不良事件的评估.

主要成果:

  • 副作用的高患病率:47%的临床和27%的实验室事件归因于抗逆转录病毒治疗.
  • 严重或严重的不良事件发生在9% (临床) 和16% (实验室) 的受影响患者中.
  • 与单一PI疗法相比,双PI和三类抗逆转录病毒治疗显示出较高的不良事件患病率 (分别为OR 2.0和3.9).

结论:

  • 观察到与HIV-1抗逆转录病毒治疗相关的有毒效应的显著流行.
  • 治疗方案和化合物特定的不良事件数据对于营销后监测和临床决策至关重要.